Loading...

CELC - Celcuity Inc.

Top Biomed Signal for 06-25-2022
Top Biomed Stock Signal: CELC


Loading Chart CELC

Stock Signal Information


Signal

Top Biomed Stock Signal: CELC
Report Date: 06-25-2022
Symbol: CELC - Celcuity Inc.
Sector:
Industry:
Top Biomed Stock Signal: CELC

  CELC Technical Analysis

Company Contact

Celcuity Inc. (CELC)
16305 36th Ave N Ste 100
Minneapolis, MINNESOTA 55446
Phone: 17633920767
Website: http://www.celcuity.com
CEO: Mr. Brian F. Sullivan

CELC, Celcuity Inc.

CELC Celcuity Inc. Logo Image

NASDAQ, Nasdaq Capital Market


Company Profile

Celcuity, Inc. is cellular analysis company. The company is headquartered in Minneapolis, Minnesota and currently employs 26 full-time employees. The firm is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it. CELx platform provides traditional molecular diagnostics, which provides a snapshot of the genetic mutations present in a patient’s tumor because they analyze dead cells. Using dead cells prevents molecular diagnostics from analyzing in real-time the dynamic cellular activities, known as cell signaling, that regulate cell proliferation or survival.